Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
ANTX on Nasdaq
Joseph S. Zakrzewski - trading volume in the past year for AN2 Therapeutics, Inc.
Holdings reported by Joseph S. Zakrzewski for AN2 Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
406K |
$7.76M |
$19.11 |
Jan 18, 2024 |
Indirect |
|
|
| Common Stock |
98.2K |
$1.88M |
$19.11 |
Jan 18, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
64.5K |
|
|
Jun 19, 2024 |
Direct |
Common Stock |
|
Transactions reported by Joseph S. Zakrzewski for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.